Tengjun Biotechnology Corp
Tengjun Biotechnology Corp., through its subsidiaries, engages in producing, packaging, distributing, and marketing featured dandelion teas and water purifiers in the People's Republic of China. It offers black and green dandelion teas; and household water purifiers. The company was founded in 2010 and is headquartered in Jining, China.
Tengjun Biotechnology Corp (TJBH) - Total Assets
Latest total assets as of June 2023: $438.96 Million USD
Based on the latest financial reports, Tengjun Biotechnology Corp (TJBH) holds total assets worth $438.96 Million USD as of June 2023.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Tengjun Biotechnology Corp - Total Assets Trend (2015–2022)
This chart illustrates how Tengjun Biotechnology Corp’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Tengjun Biotechnology Corp - Asset Composition Analysis
Current Asset Composition (December 2022)
Tengjun Biotechnology Corp's total assets of $438.96 Million consist of 86.3% current assets and 13.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 4.8% |
| Accounts Receivable | $46.32 Million | 79.0% |
| Inventory | $1.00 Million | 1.7% |
| Property, Plant & Equipment | $8.06 Million | 13.8% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2015–2022)
This chart illustrates how Tengjun Biotechnology Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Tengjun Biotechnology Corp's current assets represent 86.3% of total assets in 2022, a decrease from 100.0% in 2015.
- Cash Position: Cash and equivalents constituted 4.8% of total assets in 2022, down from 100.0% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2015.
- Asset Diversification: The largest asset category is accounts receivable at 79.0% of total assets.
Tengjun Biotechnology Corp Competitors by Total Assets
Key competitors of Tengjun Biotechnology Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
General Mills Inc
NYSE:GIS
|
USA | $32.55 Billion |
|
Maniker F & G Co. Ltd
KQ:195500
|
Korea | ₩123.42 Billion |
|
Xiwang Foodstuffs Co Ltd
SHE:000639
|
China | CN¥6.08 Billion |
|
Nanfang Black Sesame Group Co Ltd
SHE:000716
|
China | CN¥4.57 Billion |
|
CNFC Overseas Fishery Co Ltd
SHE:000798
|
China | CN¥5.88 Billion |
|
Henan Shuanghui Investment & Development Co Ltd
SHE:000895
|
China | CN¥40.64 Billion |
|
Xinjiang Chalkis Co Ltd
SHE:000972
|
China | CN¥1.25 Billion |
|
Daehan Flour Mills Co Ltd
KO:001130
|
Korea | ₩1.61 Trillion |
Tengjun Biotechnology Corp - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Tengjun Biotechnology Corp generates 2.56x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, Tengjun Biotechnology Corp generates $ 19.35 in net profit.
Tengjun Biotechnology Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.02 | 0.70 | 0.02 |
| Quick Ratio | 1.01 | 0.65 | 0.02 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $6.80 Million | $ -6.97 Million | $ -245.15K |
Tengjun Biotechnology Corp - Advanced Valuation Insights
This section examines the relationship between Tengjun Biotechnology Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 13.56 |
| Latest Market Cap to Assets Ratio | 2.55 |
| Asset Growth Rate (YoY) | 317.9% |
| Total Assets | $58.63 Million |
| Market Capitalization | $149.42 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Tengjun Biotechnology Corp's assets at a significant premium ( 2.55x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Tengjun Biotechnology Corp's assets grew by 317.9% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Tengjun Biotechnology Corp (2015–2022)
The table below shows the annual total assets of Tengjun Biotechnology Corp from 2015 to 2022.
| Year | Total Assets | Change |
|---|---|---|
| 2022-12-31 | $58.63 Million | +317.88% |
| 2021-12-31 | $14.03 Million | +136915.49% |
| 2020-12-31 | $10.24K | +138.19% |
| 2019-12-31 | $4.30K | +7.48% |
| 2018-12-31 | $4.00K | +20.01% |
| 2017-12-31 | $3.33K | -23.68% |
| 2016-12-31 | $4.37K | +143.29% |
| 2015-12-31 | $1.79K | -- |